A voluntary product recall that was all over the news from DePuy Orthopedics, a subsidiary of Johnson & Johnson, involved two of its DePuy hip replacement implants. Its website states that data received by the company shows that more people than expected who received the ASR Hip System experienced pain or other problems. The two recalled hip replacement systems are the ASR XL Acetabular System and the DePuy ASR Hip Resurfacing System.
Chicago product liability attorney Steve Levin reported in an interview that “There are absolutely problems. These hip replacements are clearly failing.” According to Illinois injury attorney Steve Levin so far, there is a failure rate of somewhere between 10 and 15 percent. Levin’s firm of Levin & Perconti is currently investigating complaints from clients with DePuy ASR Hip Systems and gathering data in preparation for coming suits. So far, Levin is focusing on two problems: the difficulty of the replacement resulting in dislocation and the metal-on-metal friction. According to Steve Levin, “There is a chemical reaction between chromium and cobalt that can be toxic to certain people – they are going to have blood monitored for possible future problems.” The ASR hip replacement systems were marketed to a young cohort – people between the ages of 35 and 50, though some older Americans were also implanted with the products.
Steve Levin indicated that “clients who have problems may have to undergo revision surgeries. The redo can present problems as well. It doesn’t always work and it has a greater chance of failure. A person who could have a lifetime of pain.” Levin envisioned the anxiety of individuals who have one of these implants, but have not yet experienced any product liability problems.
Follow the link to Lawyers and Settlements to read more about the product recall.